NCT05004428View on ClinicalTrials.gov

A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)

CompletedOBSERVATIONAL
Enrollment

336,376

Participants

Timeline

Start Date

August 14, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

February 11, 2022

Conditions
Type 2 Diabetes MellitusChronic Kidney Disease
Interventions
OTHER

No intervention

Retrospective population-based study utilizing administrative data without any intervention.

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY